RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
-9.4%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$1.68B
AUM Growth
-$184M
(-9.9%)
Cap. Flow
+$109M
Cap. Flow
% of AUM
6.47%
Top 10 Holdings %
Top 10 Hldgs %
74.63%
Holding
34
New
9
Increased
4
Reduced
5
Closed
2
Top Buys
| 1 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$70.3M |
| 2 |
Travere Therapeutics
TVTX
|
$46.2M |
| 3 |
Rhythm Pharmaceuticals
RYTM
|
$33.2M |
| 4 |
Solid Biosciences
SLDB
|
$19.5M |
| 5 |
Kodiak Sciences
KOD
|
$14.7M |
Top Sells
| 1 |
ZGNX
Zogenix, Inc.
ZGNX
|
$58.5M |
| 2 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
$28.3M |
| 3 |
GTHX
G1 Therapeutics, Inc. Common Stock
GTHX
|
$14.8M |
| 4 |
Axsome Therapeutics
AXSM
|
$13.7M |
| 5 |
X4 Pharmaceuticals
XFOR
|
$4.87M |
Sector Composition
| 1 | Healthcare | 97.05% |
| 2 | Technology | 0.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dynavax Technologies
DVAX
$1.17B
| $8.46M | 0.5% |
+2,365,912
| New | +$8.46M |
|
|
IGMS
27
DELISTED
IGM Biosciences
IGMS
| $8.28M | 0.49% |
+466,368
| New | +$8.28M |
|
|
28
X4 Pharmaceuticals
XFOR
$81.7M
| $6.08M | 0.36% |
15,937
-12,776
| -44% | -$4.87M |
|
|
ODT
29
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $5.21M | 0.31% |
200,000
| – | – |
|
|
CMRX
30
DELISTED
Chimerix, Inc.
CMRX
| $4.19M | 0.25% |
+1,782,202
| New | +$4.19M |
|
31
ESSA Pharma
EPIX
$11M
| $3.37M | 0.2% |
+1,000,000
| New | +$3.37M |
|
32
Senseonics Holdings
SENS
$365M
| $2.7M | 0.16% |
+2,727,273
| New | +$2.7M |
|
|
GTHX
33
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| – | – |
-483,990
| Closed | -$14.8M |
|
|
SWAV
34
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| – | – |
-495,608
| Closed | -$28.3M |
|